                         SEQUENCE LISTING

<110>  ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE
       LUCAS, ALEXANDRA
       YARON, JORDAN
       LIM, EFREM
 
<120>  SERINE PROTEINASE INHIBITORS: SERP-1 AND SERP-1 RCL-DERIVED 
       PEPTIDES EFFECT ON MICROBIOME COMPOSITION AND USES THEREOF

<130>  131849-252219

<150>  62/792,201
<151>  2019-01-14

<160>  9     

<170>  PatentIn version 3.5

<210>  1
<211>  350
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Serp-1 recombinant polypeptide

<400>  1

Met Lys Tyr Leu Val Leu Val Leu Cys Leu Thr Ser Cys Ala Cys Arg 
1               5                   10                  15      


Asp Ile Gly Leu Trp Thr Phe Arg Tyr Val Tyr Asn Glu Ser Asp Asn 
            20                  25                  30          


Val Val Phe Ser Pro Tyr Gly Leu Thr Ser Ala Leu Ser Val Leu Arg 
        35                  40                  45              


Ile Ala Ala Gly Gly Asn Thr Lys Arg Glu Ile Asp Val Pro Glu Ser 
    50                  55                  60                  


Val Val Glu Asp Ser Asp Ala Phe Leu Ala Leu Arg Glu Leu Phe Val 
65                  70                  75                  80  


Asp Ala Ser Val Pro Leu Arg Pro Glu Phe Thr Ala Glu Phe Ser Ser 
                85                  90                  95      


Arg Phe Asn Thr Ser Val Gln Arg Val Thr Phe Asn Ser Glu Asn Val 
            100                 105                 110         


Lys Asp Val Ile Asn Ser Tyr Val Lys Asp Lys Thr Gly Gly Asp Val 
        115                 120                 125             


Pro Arg Val Leu Asp Ala Ser Leu Asp Arg Asp Thr Lys Met Leu Leu 
    130                 135                 140                 


Leu Ser Ser Val Arg Met Lys Thr Ser Trp Arg His Val Phe Asp Pro 
145                 150                 155                 160 


Ser Phe Thr Thr Asp Gln Pro Phe Tyr Ser Gly Asn Val Thr Tyr Lys 
                165                 170                 175     


Val Arg Met Met Asn Lys Ile Asp Thr Leu Lys Thr Glu Thr Phe Thr 
            180                 185                 190         


Leu Arg Asn Val Gly Tyr Ser Val Thr Glu Leu Pro Tyr Lys Arg Arg 
        195                 200                 205             


Gln Thr Ala Met Leu Leu Val Val Pro Asp Asp Leu Gly Glu Ile Val 
    210                 215                 220                 


Arg Ala Leu Asp Leu Ser Leu Val Arg Phe Trp Ile Arg Asn Met Arg 
225                 230                 235                 240 


Lys Asp Val Cys Gln Val Val Met Pro Lys Phe Ser Val Glu Ser Val 
                245                 250                 255     


Leu Asp Leu Arg Asp Ala Leu Gln Arg Leu Gly Val Arg Asp Ala Phe 
            260                 265                 270         


Asp Pro Ser Arg Ala Asp Phe Gly Gln Ala Ser Pro Ser Asn Asp Leu 
        275                 280                 285             


Tyr Val Thr Lys Val Leu Gln Thr Ser Lys Ile Glu Ala Asp Glu Arg 
    290                 295                 300                 


Gly Thr Thr Ala Ser Ser Asp Thr Ala Ile Thr Leu Ile Pro Arg Asn 
305                 310                 315                 320 


Ala Leu Thr Ala Ile Val Ala Asn Lys Pro Phe Met Phe Leu Ile Tyr 
                325                 330                 335     


His Lys Pro Thr Thr Thr Val Leu Phe Met Gly Thr Ile Thr 
            340                 345                 350 


<210>  2
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Reactive Center Loop Polypeptide sequence of for a serine 
       protease inhibitor

<400>  2

Gly Thr Thr Ala Ser Ser Asp Thr Ala Ile Thr Leu Ile Pro Arg 
1               5                   10                  15  


<210>  3
<211>  18
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide primer 65F

<400>  3
gtcagggccc agtccgta                                                     18


<210>  4
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide primer 65R

<400>  4
tggccctcta ccttctgttg a                                                 21


<210>  5
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Modified S-7 peptide MPS7-8

<400>  5

Gly Thr Thr Ala Ser Ser Asp Thr Ala Ile Thr Leu Glu Pro Arg 
1               5                   10                  15  


<210>  6
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Modified S7 peptide MPS7-9

<400>  6

Gly Thr Thr Ala Ser Ser Asp Thr Ala Ile Thr Asp Glu Pro Arg 
1               5                   10                  15  


<210>  7
<211>  253
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  ASV1 nucleotide sequence

<400>  7
tacgtaggtg gcaagcgttg tccggattta ttgggcgtaa agcgagcgca ggcggtttct       60

taagtctgat gtgaaagccc ccggctcaac cggggagggt cattggaaac tgggagactt      120

gagtgcagaa gaggagagtg gaattccatg tgtagcggtg aaatgcgtag atatatggag      180

gaacaccagt ggcgaaggcg gctctctggt ctgtaactga cgctgaggct cgaaagcgtg      240

gggagcaaac agg                                                         253


<210>  8
<211>  253
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  ASV4 nucleotide sequence

<400>  8
tacgtaggtg gcaagcgttg tccggattta ttgggcgtaa agcgcgcgca ggtggtttct       60

taagtctgat gtgaaagccc acggctcaac cgtggaaggt cattggaaac tgggaaactt      120

gagtgcagaa gaggaaagtg gaattccaag tgtagcggtg aaatgcgtag atatttggag      180

gaacaccagt ggcgaaggcg actttctggt ctgtaactga cactgaggcg cgaaagcgtg      240

gggagcaaac agg                                                         253


<210>  9
<211>  253
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  ASV123 nucleotide sequence

<400>  9
tacgtagggt gcaagcgttg tccggaatta ttgggcgtaa agagctcgta ggcggtttgt       60

cgcgtctgct gtgaaatctg ggggctcaac ccccagcctg cagtgggtac gggcagacta      120

gagtgcggta ggggagattg gaattcctgg tgtagcggtg gaatgcgcag atatcaggag      180

gaacaccgat ggcgaaggca gatctctggg ccgtaactga cgctgaggag cgaaagcatg      240

gggagcgaac agg                                                         253


